What a typical hydropower dam looks like. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Lithium Universe (ASX:LU7) announced on Wednesday it has made an application to Hydro-Quebec in Canada for renewable electricity to power its lithium carbonate plant.

Shares were up 3.85% to 2.7cps in the first hour of trades.

The company is seeking 18MW worth of hydro power, a figure reached in an engineering study, for train 1 of a 16,000tpa capacity asset.

This will also help the company close the “North American lithium processing gap.”

Lithium Universe last month selected Becancour Port as the ideal location for its refinery operations given the desirable import logistics routes.

Spodumene will be shipped to the port, then on to the refinery, where Lithium Universe can begin producing lithium carbonate with a view toward inclusion in batteries.

The company is headed by the same man in charge of Altech, Iggy Tan. That venture sees Altech heavily invested in developing energy storage battery technology.

“The strategic move to secure green electricity from Hydro-Québec
marks a significant step in our lithium refinery project,” Tan said.

“Our emphasis on early work streams underscores our determination to accelerate the development process. We are committed to fast-tracking the development, ensuring the refinery becomes a reality in record time.”

LU7 last traded at 2.7cps.

LU7 by the numbers
More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…